Susquehanna International Group’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $186K | Buy |
39,649
+7,799
| +24% | +$36.7K | ﹤0.01% | 5594 |
|
2025
Q1 | $116K | Buy |
31,850
+16,052
| +102% | +$58.6K | ﹤0.01% | 5809 |
|
2024
Q4 | $74.6K | Sell |
15,798
-23,793
| -60% | -$112K | ﹤0.01% | 5772 |
|
2024
Q3 | $369K | Buy |
+39,591
| New | +$369K | ﹤0.01% | 4040 |
|
2024
Q2 | – | Sell |
-16,080
| Closed | -$108K | – | 5918 |
|
2024
Q1 | $108K | Buy |
16,080
+4,749
| +42% | +$31.9K | ﹤0.01% | 4982 |
|
2023
Q4 | $73.1K | Sell |
11,331
-20,007
| -64% | -$129K | ﹤0.01% | 5447 |
|
2023
Q3 | $157K | Sell |
31,338
-23,684
| -43% | -$118K | ﹤0.01% | 4698 |
|
2023
Q2 | $387K | Buy |
55,022
+42,365
| +335% | +$298K | ﹤0.01% | 3951 |
|
2023
Q1 | $78.5K | Buy |
+12,657
| New | +$78.5K | ﹤0.01% | 5326 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 6137 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 6366 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 6079 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 5975 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 6012 |
|
2021
Q1 | – | Sell |
-27,939
| Closed | -$566K | – | 5351 |
|
2020
Q4 | $566K | Buy |
+27,939
| New | +$566K | ﹤0.01% | 3270 |
|